Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model
DOI: https://doi.org/10.2147/JHC.S398713
2023-02-28
Journal of Hepatocellular Carcinoma
Abstract:Honghong Shen, 1, &ast Xianhua Gu, 2, &ast Huiyuan Li, 1 Mingyue Tang, 1 Xinwei Li, 1 Yue Zhang, 1 Fang Su, 1 Zishu Wang 1 1 Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China; 2 Department of Gynecology Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fang Su; Zishu Wang, Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, 287 Changhuai Road, Bengbu, Anhui, 233004, People's Republic of China, Tel +8613605523272 ; +86 18909620171, Email ; Introduction: Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer. It is the fourth leading cause of cancer-related death worldwide. Deregulation of the ATF/CREB family is associated with the progression of metabolic homeostasis and cancer. Because the liver plays a central role in metabolic homeostasis, it is critical to assess the predictive value of the ATF/CREB family in the diagnosis and prognosis of HCC. Methods: Using data from The Cancer Genome Atlas (TCGA), this research evaluated the expression, copy number variations, and frequency of somatic mutations of 21 genes in the ATF/CREB family in HCC. A prognostic model based on the ATF/CREB gene family was developed via Lasso and Cox regression analyses, with the TCGA cohort serving as the training dataset and the International Cancer Genome Consortium (ICGC) cohort serving as the validation set. Kaplan-Meier and receiver operating characteristic analyses verified the accuracy of the prognostic model. Furthermore, the association among the prognostic model, immune checkpoints, and immune cells was examined. Results: High-risk patients exhibited an unfavorable outcome as opposed to those in the low-risk category. Multivariate Cox analysis revealed that the risk score calculated based on the prognostic model was an independent prognostic factor for HCC. Analysis of immune mechanisms revealed that the risk score had a positive link to the expression of immune checkpoints, particularly CD274, PDCD1, LAG3, and CTLA4. Differences in immune cells and immune-associated roles were found between the high- and low-risk patients, as determined by single-sample gene set enrichment analysis. The core genes ATF1, CREB1, and CREB3 in the prognostic model were shown to be upregulated in HCC tissues as opposed to adjoining normal tissues, and the 10-year overall survival (OS) rate was worse among patients with elevated expression levels of ATF1, CREB1, and CREB3. Elevated expression levels of ATF1, CREB1, and CREB3 in HCC tissues were confirmed by qRT-PCR and immunohistochemistry studies. Conclusion: According to the results of our training set and test set, the risk model based on the six ATF/CREB gene signatures predicting prognosis has certain predictive accuracy in predicting the survival of HCC patients. This study provides novel insights into the individualized treatment of patients with HCC. Keywords: hepatocellular carcinoma, ATF/CREB transcription factors, immune checkpoints, prognostic model, nomogram Initially identified by their capacity for binding to the consensus ATF/CRE domain "TGACGTCA", the ATF/CREB family of transcriptional regulators is a large class of basic region-leucine zipper (bZip) proteins. 1 The ATF/CREB transcription factor family currently has 21 members, namely, ATF1, ATF2, ATF3, ATF4, ATF5, ATF6, ATF7, BATF, BATF2, BATF3, CREB1, CREB3, CREB5, CREM, CREB3L1, CREB3L2, CREB3L3, CPEB4, CPEB4, JDP2, ATF6B , and CREBZF . 2 The advancement of type 2 diabetes mellitus (T2DM) is linked to the deregulation of ATF/CREB family signaling. 2 The liver maintains systemic glucose homeostasis and regulates hormones, which include glucocorticoids, glucagon, and insulin. 3,4 The ATF/CREB network of transcriptional regulators is necessary for the process of gluconeogenesis as well as the maintenance of systemic glucose homeostasis. 5–7 ATF3 , for instance, plays a role in mediating the inhibition impacts of ethanol on hepatic glucose production; 8 CRTC2 , a CREB1 coactivator, promotes hepatic gluconeogenesis; 9 and CREBH is responsible for the circadian regulation of glucose homeostasis through its regulation of hepatic gluconeogenesis and glycogenolysis. 10 The ATF/CREB family members are closely associated with HCC. 11,12 For exa -Abstract Truncated-
oncology